Vaccine News
Vaccine reduces HPV prevalence among teen girls by 86% in 10 years
May 6, 2019
HPV Vaccine Driving Down Cervical Pre-Cancer Rates
April 18, 2019
The human papillomavirus (HPV) vaccine is largely responsible for a decline in precancerous cervical lesions among young women in the United States, a new government report shows.
The number of these precancerous lesions detected during screening went down from an estimated 216,000 cases in 2008 to 196,000 cases in 2016, researchers from the U.S. Centers for Disease Control and Prevention found.
Dating after 40? The millions who are should get the HPV vaccine
April 16, 2019
Anyone under 45 who plans to be sexually active in the future should not miss this window of opportunity and should take action before reaching the age cutoff. Talk to your doctor or pharmacist about getting the HPV vaccine. Three shots, a copay and some shoulder soreness are a small price to pay to be inoculated from cancer-causing viruses.
The HPV vaccine is important for preteens and teenagers. What about older women?
April 13, 2019
‘Is Gardasil 9 right for me?” my patient asked during a recent office visit.
She is 45, recently divorced from her husband of 20 years and crafting her online dating profile. She’s also wondering whether she is a candidate for the vaccine that protects against nine strains of the human papilloma virus (HPV) — a virus that causes most cervical, oral and anal cancer.
Controversial HPV Vaccine Shown to be Highly Effective in Wiping Out Cervical Cancer
March 31, 2019
An Educational Intervention to Improve HPV Vaccination: A Cluster Randomized Trial
January 16, 2019
No Ovarian Failure Risk After HPV Vaccine, Study Finds
December 12, 2018
WHY PARENTS DON’T VACCINATE THEIR KIDS AGAINST HPV
October 25, 2018
FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
October 5, 2018
FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
October 5, 2018
No Ovarian Failure Risk After HPV Vaccine, Study Finds
August 22, 2018
HPV vaccine cuts cancer-causing infection
June 18, 2018
HPV Vaccine Cuts Cancer Causing Infection
June 18, 2018
Doctors Can Increase Vaccination Rates In Kids Using New Approach, Study Finds
May 30, 2018
This is a tale where the moral of the story is this: persistence can make a difference.
The HPV vaccine (human papilloma virus vaccine, Gardisil) has been available for nearly 12 years but actually getting children and teens to complete vaccination with it has been quite a challenge with dismally low vaccination rates.
Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination
May 7, 2018
Effect of Health Care Professional Communication Training on Adolescent HPV
May 7, 2018
Florida man shares story of how he survived HPV cancer
April 30, 2018
Jason Mendelsohn was pondering a question during a financial exam in 2014 when his fingers grazed his neck, making him notice a bump he hadn’t felt before.
He consulted his father, a doctor, who told him they’d need to call an ear, nose and throat physician. This led to a doctor’s consultation, which eventually led to a diagnosis. At 44, he was told he had HPV-related throat cancer.
Cancer Prevention Through HPV Vaccination in Your Practice: An Action Guide for Nurses and Medical Assistants
February 1, 2018
Cancer Prevention Through HPV Vaccination: An Action Guide for Large Health Systems
February 1, 2018
CDC recommends only two HPV shots for younger adolescents
October 25, 2016
CDC today recommended that 11- to 12-year-olds receive two doses of HPV vaccine at least six months apart rather than the previously recommended three doses to protect against cancers caused by human papillomavirus (HPV) infections. Teens and young adults who start the series later, at ages 15 through 26 years, will continue to need three doses of HPV vaccine to protect against cancer-causing HPV infection.
HPV Sharply Reduced in Teenage Girls Following Vaccine, Study Says
February 23, 2016
A vaccine introduced a decade ago to combat the sexually transmitted virus that causes cervical cancer has already reduced the virus’s prevalence in teenage girls by almost two-thirds, federal researchers said Monday.
Gardasil 9 Indication Now Covers More Male Patients
December 17, 2015
Merck announced that the Food and Drug Administration (FDA) has expanded the age indication for Gardasil 9 (human papillomavirus 9-valent vaccine [recombinant]) in males. It now includes use in males aged 16–26 for the prevention of anal cancer caused by human papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 59; precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58; and genital warts caused by HPV types 6 and 11.
PAS: Communication style influences HPV vaccination
June 2, 2015
More adolescents received the HPV vaccine when the vaccine was discussed in the context of other vaccines, and when the providers said they expected that the vaccine would be administered at the visit, results from a multisite study suggest.
Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage
June 2, 2015
Vaccines against human papillomavirus (HPV) are recommended for routine use in adolescents aged 11 to 12 years in the United States, but uptake remains suboptimal. Educational interventions focused on parents and patients to increase coverage have not generally demonstrated effectiveness.
Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study
September 6, 2014
The goal of this study was to identify the rationale by parents/guardians and providers for delaying or administering human papillomavirus (HPV) vaccination to girls.
HPV vaccine safe for teens, provides long-term benefits
August 27, 2014
"When administered to adolescents, the HPV4 vaccine demonstrated durability in clinically effective protection and sustained antibody titers over eight years," concluded the researchers.
Scandinavia study finds HPV vaccine safe
October 13, 2013
A new study from the Karolinska Institutet in Sweden found no association between the human papillomavirus (HPV) vaccine and short- or long-term health concerns.